Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie
Standard
Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie. / Windler, E; Nitschmann, S.
in: INTERNIST, Jahrgang 57, Nr. 1, 01.2016, S. 102-103.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
Windler, E & Nitschmann, S 2016, 'Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie', INTERNIST, Jg. 57, Nr. 1, S. 102-103. https://doi.org/10.1007/s00108-015-3848-z
APA
Windler, E., & Nitschmann, S. (2016). Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie. INTERNIST, 57(1), 102-103. https://doi.org/10.1007/s00108-015-3848-z
Vancouver
Windler E, Nitschmann S. Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie. INTERNIST. 2016 Jan;57(1):102-103. https://doi.org/10.1007/s00108-015-3848-z
Bibtex
@article{6b7fb9a828904b5badb3709dd8ee256d,
title = "Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie",
keywords = "Diabetes Mellitus, Type 1/drug therapy, Diabetes Mellitus, Type 2/drug therapy, Humans, Hypoglycemic Agents/therapeutic use",
author = "E Windler and S Nitschmann",
note = "Editorial Material",
year = "2016",
month = jan,
doi = "10.1007/s00108-015-3848-z",
language = "Deutsch",
volume = "57",
pages = "102--103",
journal = "INTERNIST",
issn = "0020-9554",
publisher = "Springer",
number = "1",
}
RIS
TY - JOUR
T1 - Neue Therapieoption bei Diabetes mellitus Typ 2: EMPA-REG-Studie
AU - Windler, E
AU - Nitschmann, S
N1 - Editorial Material
PY - 2016/1
Y1 - 2016/1
KW - Diabetes Mellitus, Type 1/drug therapy
KW - Diabetes Mellitus, Type 2/drug therapy
KW - Humans
KW - Hypoglycemic Agents/therapeutic use
U2 - 10.1007/s00108-015-3848-z
DO - 10.1007/s00108-015-3848-z
M3 - Andere (Vorworte u.ä.)
C2 - 26634255
VL - 57
SP - 102
EP - 103
JO - INTERNIST
JF - INTERNIST
SN - 0020-9554
IS - 1
ER -
